Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Health Services Research
Published in: BMC Health Services Research 1/2024

Open Access 01-12-2024 | Arthritis | Research

Development of a complex Interdisciplinary Nurse-coordinated SELf-MAnagement (INSELMA) intervention for patients with inflammatory arthritis

Authors: Jette Primdahl, Ann Bremander, Oliver Hendricks, Mikkel Østergaard, Kristine Marie Latocha, Lena Andersen, Kim Vilbaek Jensen, Bente Appel Esbensen

Published in: BMC Health Services Research | Issue 1/2024

Login to get access

Abstract

Background

Apart from a consistent focus on treating inflammation, patients with inflammatory arthritis (IA) report a range of unmet needs. Many experience not only residual symptoms but also various other physical, psychological, and social effects. Therefore, this study aimed to develop a complex Interdisciplinary Nurse-coordinated self-management (INSELMA) intervention for patients with IA, as an add-on treatment to usual outpatient care for those with substantial disease impact.

Methods

This study followed the British Medical Research Council’s updated framework for developing complex interventions. The process encompassed the following steps: (1) The evidence base was identified; (2) workshops were held, involving 38 relevant stakeholders (managers, physicians, nurses, physiotherapists, occupational therapists, social workers, psychologists from hospitals and municipalities, and two patient research partners), to discuss and further develop the preliminary ideas; (3) relevant theories were identified (i.e., self-efficacy, acceptance and commitment therapy, and health literacy); (4) the intervention was modeled and remodeled and (5) the results, describing the final INSELMA intervention and outcomes.

Results

The INSELMA intervention encompasses an initial biopsychosocial assessment, which is performed by a rheumatology nurse. Then, activities that the participant wishes to improve are identified and goals are set. The nurse refers the participant to a multidisciplinary team and coordinates their support and relevant services in the participant’s municipality. In addition, the health professionals have the opportunity to hold two interdisciplinary conferences during the intervention period. The participant and the health professionals work to achieve the set goals during a 6-month period, which ends with a status assessment and a discussion of further needs. The INSELMA intervention aims to increase self-management, reduce the impact of IA (e.g., pain, fatigue, sleep problems, and absenteeism), and increase self-efficacy, quality of life, mental well-being, work ability, and physical activity.

Conclusions

The development of the INSELMA intervention involved stakeholders from two Danish rheumatology outpatient clinics, patient research partners and municipalities. We believe that we have identified important mechanisms to increase the self-management and quality of life of people with IA and to decrease the disease impact in those who are substantially affected. The health professionals involved have developed competences in delivering the intervention and it is ready to be tested in a feasibility study.
Appendix
Available only for authorised users
Literature
1.
Smolen JS, Aletaha D, Barton A, Burmester GR, Emery P, Firestein GS, et al. Rheumatoid arthritis. Nat Reviews Disease Primers. 2018;4:18001.PubMedCrossRef
2.
3.
Gladman DD, Antoni C, Mease P, Clegg DO, Nash P. Psoriatic arthritis: epidemiology, clinical features, course, and outcome. Ann Rheum Dis. 2005;64(Suppl 2):ii14–7.PubMedPubMedCentral
4.
Soussi BG, Cordtz RL, Kristensen S, Bork CS, Christensen JH, Schmidt EB, et al. Incidence and prevalence of rheumatoid arthritis in Denmark from 1998 to 2018: a nationwide register-based study. Scand J Rheumatol. 2022;51(6):481–9.PubMedCrossRef
5.
Egeberg A, Kristensen LE, Thyssen JP, Gislason GH, Gottlieb AB, Coates LC, et al. Incidence and prevalence of psoriatic arthritis in Denmark: a nationwide register linkage study. Ann Rheum Dis. 2017;76(9):1591–7.PubMedCrossRef
6.
7.
Stolwijk C, van Onna M, Boonen A, van Tubergen A. Global prevalence of Spondyloarthritis: a systematic review and Meta-regression analysis. Arthritis Care Res. 2016;68(9):1320–31.CrossRef
8.
Smolen JS. Treat-to-target as an approach in inflammatory arthritis. Curr Opin Rheumatol. 2016;28(3):297–302.PubMedCrossRef
9.
Cook MJ, Diffin J, Scire CA, Lunt M, MacGregor AJ, Symmons DP, et al. Predictors and outcomes of sustained, intermittent or never achieving remission in patients with recent onset inflammatory polyarthritis: results from the Norfolk Arthritis Register. Rheumatology (Oxford). 2016;55(9):1601–9.PubMedCrossRef
10.
Lubrano E, Scriffignano S, Perrotta FM. Residual Disease Activity and Associated Factors in psoriatic arthritis. J Rhuematol. 2020;47(10):1490–5.CrossRef
11.
van Mens LJJ, van de Sande MGH, Fluri IA, Atiqi S, van Kuijk AWR, Baeten DLP. Residual Disease activity and treatment adjustments in psoriatic arthritis in current clinical practice. Arthritis Res Therapy. 2017;19(1):226.CrossRef
12.
Liu V, Fong W, Kwan YH, Leung YY. Residual Disease Burden in patients with Axial Spondyloarthritis and Psoriatic Arthritis despite Low Disease Activity States in a multiethnic Asian Population. J Rhuematol. 2021;48(5):677–84.CrossRef
13.
de Hair MJH, Jacobs JWG, Schoneveld JLM, van Laar JM. Difficult-to-treat rheumatoid arthritis: an area of unmet clinical need. Rheumatology (Oxford). 2018;57(7):1135–44.PubMed
14.
Ishida M, Kuroiwa Y, Yoshida E, Sato M, Krupa D, Henry N, et al. Residual symptoms and Disease burden among patients with rheumatoid arthritis in remission or low Disease activity: a systematic literature review. Mod Rheumatol. 2018;28(5):789–99.PubMedCrossRef
15.
Figus FA, Piga M, Azzolin I, McConnell R, Iagnocco A. Rheumatoid arthritis: extra-articular manifestations and comorbidities. Autoimmun rev. 2021;20(4):102776.PubMedCrossRef
16.
Scriffignano S, Perrotta FM, De Socio A, Lubrano E. Role of comorbidities in spondyloarthritis including psoriatic arthritis. Clin Rheumatol. 2019;38(1):3–10.PubMedCrossRef
17.
Taylor PC, Atzeni F, Balsa A, Gossec L, Müller-Ladner U, Pope J. The Key comorbidities in patients with rheumatoid arthritis: a narrative review. J Clin Med. 2021;10(3).
18.
Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, et al. EULAR recommendations for Cardiovascular Disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. 2017;76(1):17–28.PubMedCrossRef
19.
Moltó A, Dougados M. Comorbidities in spondyloarthritis including psoriatic arthritis. Best Pract Res Clin Rheumatol. 2018;32(3):390–400.PubMedCrossRef
20.
21.
Sossong B, Felder S, Wolff M, Kruger K. Evaluating the consequences of rheumatoid arthritis. Eur J Health Economics: HEPAC: Health Econ Prev care. 2017;18(6):685–96.CrossRef
22.
Cooper NJ. Economic burden of rheumatoid arthritis: a systematic review. Rheumatology (Oxford). 2000;39(1):28–33.PubMedCrossRef
23.
Uhlig T, Moe RH, Kvien TK. The burden of Disease in rheumatoid arthritis. PharmacoEconomics. 2014;32(9):841–51.PubMedCrossRef
24.
25.
Barlow J, Wright C, Sheasby J, Turner A, Hainsworth J. Self-management approaches for people with chronic conditions: a review. Patient Educ Couns. 2002;48(2):177–87.PubMedCrossRef
26.
Zuidema RM, Repping-Wuts H, Evers AW, Van Gaal BG, Van Achterberg T. What do we know about rheumatoid arthritis patients’ support needs for self-management? A scoping review. Int J Nurs Stud. 2015;52(10):1617–24.PubMedCrossRef
27.
Novak M, Costantini L, Schneider S, Beanlands H. Approaches to self-management in chronic Illness. Semin Dial. 2013;26(2):188–94.PubMedCrossRef
28.
Nikiphorou E, Santos EJF, Marques A, Böhm P, Bijlsma JW, Daien CI, et al. 2021 EULAR recommendations for the implementation of self-management strategies in patients with inflammatory arthritis. Ann Rheum Dis. 2021;80(10):1278–85.PubMedCrossRef
29.
Bech B, Primdahl J, van Tubergen A, Voshaar M, Zangi HA, Barbosa L, et al. 2018 update of the EULAR recommendations for the role of the nurse in the management of chronic inflammatory arthritis. Ann Rheum Dis. 2020;79(1):61–8.PubMedCrossRef
30.
McCormack B, Borg M, Cardiff S, Dewing J, Jacobs G, Janes N, et al. Person-centredness - the ‘state’ of the art. Int Pract Dev J. 2015;5(1):1–15.CrossRef
31.
Lorig KR, Holman H. Self-management education: history, definition, outcomes, and mechanisms. Annals of Behavioral Medicine: A Publication of the Society of Behavioral Medicine. 2003;26(1):1–7.PubMedCrossRef
32.
33.
Levack W, Dean SG. Chapter 4. Processes in rehabilitation. Interprofessional Rehabilitation A person-centred approach. 1th edition. West Sussex, United Kingdom: Wiley-Blackwel; 2012. p. 195.
34.
Pedersen MB, Thinggaard P, Geenen R, Rasmussen MU, Wit M, March L, et al. Biopsychosocial Rehabilitation for Inflammatory Arthritis and Osteoarthritis patients: a systematic review and Meta-analysis of Randomized trials. Arthritis care & research; 2021.
35.
Gittell JH. Effektivitet i sundhedsvæsenet– samarbejde, fleksibilitet og kvalitet [Effectiveness in healthcare - collaboration. flexibility and quality]: Munksgaard; 2012.
36.
Breimo JIP. Captured by care: an institutional ethnography on the work of being in a Rehabilitation process in Norway. J Sociol Social Welf. 2015;42(2):13–29.
37.
Buch MS, Jensen MCF, Brorholt G. Sammenhæng i patientforløb - hvilke modeller Og Anbefalinger Er Der, Og Hvordan Kan De bruges i praksis? [Coherence in patient pathways - which models and recommendations are there and how can they be used in practice?]. VIVE Det nationale forsknings- og analysecenter for velfærd [The national research and analysis center for welfare]; 2018.
38.
Feddersen H, Soendergaard J, Schmiddt B, Andersen L, Primdahl J. Coherent rehabilitation - experiences of people with inflammatory arthritis. Ann Rheum Dis. 2020;79:1.CrossRef
39.
Feddersen H, Søndergaard J, Andersen L, Munksgaard B, Primdahl J. Barriers and facilitators for coherent rehabilitation among people with inflammatory arthritis - a qualitative interview study. BMC Health Serv Res. 2022;22(1):1347.PubMedPubMedCentralCrossRef
40.
Skivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM, et al. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ: Br Med J. 2021;374:n2061.CrossRef
41.
Möhler R, Köpke S, Meyer G. Criteria for reporting the Development and Evaluation of Complex Interventions in healthcare: revised guideline (CReDECI 2). Trials. 2015;16:204.PubMedPubMedCentralCrossRef
42.
Damgaard A, Primdahl J, Esbensen BA, Hendricks O, Bremander A. Self-management support among persons with inflammatory arthritis: a scoping review protocol OSF Registries: OSF Registries; 2021 [Protocol for scoping review]. Available from: https://​osf.​io/​tvx82.
43.
Damgaard AJ, Primdahl J, Esbensen BA, Latocha KM, Bremander A. Self-management support needs of patients with inflammatory arthritis and the content of self-management interventions: a scoping review. Semin Arthritis Rheum. 2023;60:152203.PubMedCrossRef
44.
Primdahl J, Wagner L, Horslev-Petersen K. Being an outpatient with rheumatoid arthritis–a focus group study on patients’ self-efficacy and experiences from participation in a short course and one of three different outpatient settings. Scand J Caring Sci. 2011;25(2):394–403.PubMedCrossRef
45.
Bech B, Lykkegaard JJ, Lundbak T, Schrøder HM, Birkeland LM, Schlyter ML, et al. Patient-initiated Follow-Up (PIFU) as reorganized support for increased patient involvement - focus group discussions among patients’ with inflammatory arthritis. BMC Rheumatol. 2020;4:44.PubMedPubMedCentralCrossRef
46.
Bandura A. Self-efficacy: toward a unifying theory of behavioral change. Psychol Rev. 1977;84(2):24.CrossRef
47.
Jesus TS, Bright FA, Pinho CS, Papadimitriou C, Kayes NM, Cott CA. Scoping review of the person-centered literature in adult physical rehabilitation. Disabil Rehabil. 2021;43(11):1626–36.PubMedCrossRef
48.
Hegarty RSM, Fletcher BD, Conner TS, Stebbings S, Treharne GJ. Acceptance and commitment therapy for people with rheumatic Disease: existing evidence and future directions. Musculoskelet Care. 2020;18(3):330–41.CrossRef
49.
Aisbett B, Harris R. Lykkefælden [The happiness trap]. Dansk Psykologisk Forlag; 2010.
50.
Hughes LS, Clark J, Colclough JA, Dale E, McMillan D. Acceptance and Commitment Therapy (ACT) for Chronic Pain: a systematic review and Meta-analyses. Clin J Pain. 2017;33(6):552–68.PubMedCrossRef
51.
Du S, Dong J, Jin S, Zhang H, Zhang Y. Acceptance and Commitment Therapy for chronic pain on functioning: a systematic review of randomized controlled trials. Neurosci Biobehav Rev. 2021;131:59–76.PubMedCrossRef
52.
Apolinário-Hagen J, Drüge M, Fritsche L. Cognitive behavioral therapy, mindfulness-based cognitive Therapy and Acceptance Commitment Therapy for anxiety disorders: integrating traditional with Digital Treatment approaches. Adv Exp Med Biol. 2020;1191:291–329.PubMedCrossRef
53.
Bai Z, Luo S, Zhang L, Wu S, Chi I. Acceptance and Commitment Therapy (ACT) to reduce depression: a systematic review and meta-analysis. J Affect Disord. 2020;260:728–37.PubMedCrossRef
54.
Twohig MP, Levin ME. Acceptance and Commitment Therapy as a treatment for anxiety and depression: a review. Psychiatr Clin North Am. 2017;40(4):751–70.PubMedCrossRef
55.
Veehof MM, Trompetter HR, Bohlmeijer ET, Schreurs KM. Acceptance- and mindfulness-based interventions for the treatment of chronic pain: a meta-analytic review. Cogn Behav Ther. 2016;45(1):5–31.PubMedCrossRef
56.
Parnell TA, Stichler JF, Barton AJ, Loan LA, Boyle DK, Allen PE. A concept analysis of health literacy. Nurs Forum. 2019;54(3):315–27.PubMedCrossRef
57.
Kickbusch I, Pelikan J, Apfel F, Tsouros AD. Health literacy: the solid facts. Kickbusch, Ilona, Pelikan, Jürgen M, Apfel, Franklin & Tsouros. Agis D.: World Health Organisation, Regional Office for Europe; 2013.
58.
Bröder J, Chang P, Kickbusch I, DLevin-Zanin D, McElhinney E, Nutbeam D, et al. IUHPE position Statement on Health literacy: a practical vision for a health literate world. Global Health Promotion. 2018;25(4):9.CrossRef
59.
Kellogg Foundation W. Using Logic models to bring together planning, evaluation, and Action. Logic Model Development Guide. www.wkkf.org. W.K. Kellog Foundation; 2004.
60.
Horn KK, Jennings S, Richardson G, Vliet DV, Hefford C, Abbott JH. The patient-specific functional scale: psychometrics, clinimetrics, and application as a clinical outcome measure. J Orthop Sports Phys Ther. 2012;42(1):30–42.PubMedCrossRef
61.
Jensen NH, Aaby A, Ryom K, Maindal HT. A CHAT about health literacy - a qualitative feasibility study of the Conversational Health Literacy Assessment Tool (CHAT) in a Danish municipal healthcare centre. Scand J Caring Sci. 2021;35(4):1250–8.PubMedCrossRef
62.
Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ (Clinical Research ed). 2014;348:g1687.PubMed
63.
Loudon K, Treweek S, Sullivan F, Donnan P, Thorpe KE, Zwarenstein M. The PRECIS-2 tool: designing trials that are fit for purpose. BMJ: Br Med J. 2015;350(may08 1):h2147–h.CrossRef
64.
de Wit MP, Berlo SE, Aanerud GJ, Aletaha D, Bijlsma JW, Croucher L, et al. European League against Rheumatism recommendations for the inclusion of patient representatives in scientific projects. Ann Rheum Dis. 2011;70(5):722–6.PubMedCrossRef
65.
Thorsen H, Hansen TM, McKenna SP, Sorensen SF, Whalley D. Adaptation into Danish of the Stanford Health Assessment Questionnaire (HAQ) and the rheumatoid arthritis quality of Life Scale (RAQoL). Scand J Rheumatol. 2001;30(2):103–9.
66.
67.
Hetland ML. DANBIO–powerful research database and electronic patient record. Rheumatology (Oxford). 2011;50(1):69–77.
68.
Hewlett S, Dures E, Almeida C. Measures of fatigue: Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire (BRAF MDQ), Bristol Rheumatoid Arthritis Fatigue Numerical Rating Scales (BRAF NRS) for severity, effect, and coping, Chalder Fatigue Questionnaire (CFQ), Checklist Individual Strength (CIS20R and CIS8R), Fatigue Severity Scale (FSS), Functional Assessment Chronic Illness Therapy (Fatigue) (FACIT-F), Multi-Dimensional Assessment of Fatigue (MAF), Multi-Dimensional Fatigue Inventory (MFI), Pediatric Quality Of Life (PedsQL) Multi-Dimensional Fatigue Scale, Profile of Fatigue (ProF), Short Form 36 Vitality Subscale (SF-36 VT), and Visual Analog Scales (VAS). Arthritis care & research. 2011;63 Suppl 11:S263-86.
69.
Primdahl J, Esbensen BA, Pedersen AK, Bech B, de Thurah A. Validation of the Danish versions of the Bristol rheumatoid arthritis fatigue multi-dimensional questionnaires (BRAFs). Scand J Rheumatol. 2021:1–9.
70.
Rasmussen MU, Rydahl-Hansen S, Amris K, Samsøe BD, Mortensen EL. The adaptation of a Danish version of the Pain Self-Efficacy Questionnaire: reliability and construct validity in a population of patients with fibromyalgia in Denmark. Scand J Caring Sci. 2016;30(1):202–10.
71.
72.
Bjelland I, Dahl AA, Haug TT, Neckelmann D. The validity of the hospital anxiety and Depression Scale. An updated literature review. J Psychosom Res. 2002;52(2):69–77.
73.
Jensen MB, Jensen CE, Gudex C, Pedersen KM, Sørensen SS, Ehlers LH. Danish population health measured by the EQ-5D-5L. Scand J Public Health. 2021:14034948211058060.
74.
Maindal HT, Kayser L, Norgaard O, Bo A, Elsworth GR, Osborne RH. Cultural adaptation and validation of the health literacy questionnaire (HLQ): robust nine-dimension Danish language confirmatory factor model. Springerplus. 2016;5(1):1232.
75.
Reilly MC, Zbrozek AS, Dukes EM. The validity and reproducibility of a work productivity and activity impairment instrument. PharmacoEconomics. 1993;4(5):353–65.
76.
77.
Lubrano E, Scriffignano S, Azuaga AB, Ramirez J, Cañete JD, Perrotta FM. Assessment of the patient acceptable symptom state (PASS) in psoriatic arthritis: association with Disease activity and quality of life indices. RMD open. 2020;6(1).
78.
Maksymowych WP, Richardson R, Mallon C, van der Heijde D, Boonen A. Evaluation and validation of the patient acceptable symptom state (PASS) in patients with ankylosing spondylitis. Arthritis Rheum. 2007;57(1):133–9.PubMedCrossRef
79.
Tubach F, Ravaud P, Martin-Mola E, Awada H, Bellamy N, Bombardier C, et al. Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: results from a prospective multinational study. Arthritis Care Res. 2012;64(11):1699–707.CrossRef
80.
Joos E, Peretz A, Beguin S, Famaey JP. Reliability and reproducibility of visual analogue scale and numeric rating scale for therapeutic evaluation of pain in rheumatic patients. J Rhuematol. 1991;18(8):1269–70.
81.
Wagner E. Chronic Disease management: what will it take to improve care for chronic Illness? Effective Clin Pract. 1998;1:2–4.
82.
Damgaard AJ, Primdahl J, Esbensen BA, Latocha K, Bremander A. Self-management needs, support and interventions in people with inflammatory arthritis: a scoping review.
Metadata
Title
Development of a complex Interdisciplinary Nurse-coordinated SELf-MAnagement (INSELMA) intervention for patients with inflammatory arthritis
Authors
Jette Primdahl
Ann Bremander
Oliver Hendricks
Mikkel Østergaard
Kristine Marie Latocha
Lena Andersen
Kim Vilbaek Jensen
Bente Appel Esbensen
Publication date
01-12-2024
Publisher
BioMed Central
Published in
BMC Health Services Research / Issue 1/2024
Electronic ISSN: 1472-6963
DOI
https://doi.org/10.1186/s12913-023-10463-1

Other articles of this Issue 1/2024

BMC Health Services Research 1/2024 Go to the issue

Research

Barriers and facilitators in developing patient versions of clinical practice guidelines - qualitative interviews on experiences of international guideline producers

Research

Impact of point-of-care ultrasound use on patient referral decisions in rural Kenya: a mixed methods study

Research

Variations in healthcare utilization for mental health problems prior to suicide by socioeconomic status: a Norwegian register-based population study

Research

Exploring homecare leaders’ risk perception and the link to resilience and adaptive capacity: a multiple case study

Research

Transitioning to home and beyond following stroke: a prospective cohort study of outcomes and needs

Systematic Review

Turnover intention and its associated factors among nurses in Ethiopia: a systematic review and meta-analysis